Jan 5, 2026 07:07AM Jones Trading Starts Armata Pharmaceuticals (ARMP) at Buy

Nov 12, 2025 04:12PM Armata Pharmaceuticals, Inc. (ARMP) Misses Q3 EPS by 24c

Nov 10, 2025 07:04AM Armata opens manufacturing facility in Los Angeles

Oct 22, 2025 10:39AM Armata Pharma (ARMP) Halted, News Pending

Sep 8, 2025 07:01AM Armata publishes phage Pa223 structural study in molecular biology journal

Aug 13, 2025 05:17PM Armata Pharma (ARMP) Files $100M Mixed Shelf

Aug 12, 2025 05:56PM Armata Pharmaceuticals, Inc. (ARMP) Misses Q2 EPS by 6c

May 20, 2025 06:39AM Armata Pharmaceuticals (ARMP) PT Raised to $9 at H.C. Wainwright

May 19, 2025 07:00AM Armata Pharma (ARMP) Announces Positive Topline Data from the Phase 1b/2a diSArm Study of Intravenously Administered AP-SA02 in Complicated Staphylococcus aureus Bacteremia

May 14, 2025 04:11PM Armata Pharmaceuticals, Inc. (ARMP) Misses Q1 EPS by 4c

May 1, 2025 07:03AM Armata Pharma (ARMP) Receives $4.65M of Additional Non-Dilutive Award Funding from the U.S. DoD to Support Ongoing diSArm Trial of AP-SA02

Mar 12, 2025 05:09PM Armata Pharma (ARMP) announces secure credit agreement of $10 million with Innoviva

Dec 19, 2024 07:00AM Armata Pharma (ARMP) Reports Encouraging Results from the Phase 2 Tailwind Study of Inhaled AP-PA02

Nov 13, 2024 06:08PM Armata Pharmaceuticals, Inc. (ARMP) Tops Q3 EPS by 3c

Jul 30, 2024 07:06AM Armata Pharma (ARMP) Receives $5.25 Million of Additional Non-Dilutive Grant Funding from the U.S. Department of Defense to Support Ongoing diSArm Clinical Trial of AP-SA02

Jul 12, 2024 08:17AM H.C. Wainwright Reiterates Buy Rating on Armata Pharmaceuticals (ARMP)